Exposure to insulin degludec during pregnancy: report of a small series and review of the literature
ConclusionsIn summary, while awaiting for the results of an ongoing randomized controlled trial, data on six cases of degludec exposure during pregnancy reassuringly suggest no embryo –foetal toxicity. More information is needed before degludec can be safely recommended during pregnancy.
Source: Journal of Endocrinological Investigation - Category: Endocrinology Source Type: research
More News: Babies | Bilirubin | Diabetes | Diabetes Type 1 | Endocrinology | Insulin | Intensive Care | Lice | Perinatology & Neonatology | Pregnancy | Respiratory Medicine | Toxicology | Women